This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 12 pp 11623—11635
Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis
Figure 2. Downregulation of hsa_circ_0101145 suppressed HCC cell proliferation in vivo and in vitro. (A) RT-qPCR detection of hsa_circ_0101145 expression in HepG2 and Huh-7 cells following transfection with siRNA targeting hsa_circ_0101145 (si-circ0101145) or the negative control (NC). Data are presented as the mean ± SD. ***P < 0.001 vs. NC. (B) Flow cytometry showing the percentages of cells in G1, S, or G2 phase in HepG2 and Huh-7 cells. (C and D) CCK-8 assay showing the proliferation of HepG2 (C) and Huh-7 (D) cells. Data are presented as the mean ± SD. **P < 0.01, ***P < 0.001 vs. NC. (E and F) Colony formation assay showing proliferation of HepG2 and Huh-7 cells. Data are presented as mean ± SD. ***P < 0.001 vs. NC. (G–J) Western blot analysis of the expression of E-cadherin (epithelial marker), and N-cadherin and vimentin (mesenchymal markers). Data are presented as the mean ± SD. ***P < 0.001 vs. NC.